muscular dystrophy neuromuscular diseases
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 6 healthy control subjects 5-10 persons with confirmed diagnosis of spinal muscular atrophy 6 persons with confirmed diagnosis of fascioscapulohumeral dystrophy 6 persons with confirmed dignosis of limb girdle muscular dystrophy All persons with a neuromuscular disease have impaired function of the upper extremity with a score on the Brooke scale of 3 or 4. All persons are able to sit in a (wheel)chair with a low back rest
Exclusion criteria
Exclusion criteria: Other diseases impairing arm function inability to come to the movement analysis laboratory inability to cooperate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Registration of single movements: Shoulder abduction (straight arm), shoulder anteflexion (straight arm) shoulder abduction (elbow flexed 90) shoulder anteflexion (elbow flexed 90) shoulder internal rotation, shoulder adduction in horizontal plane (Only with arm support) Movement Registration of functional movements: Bringing the hand to the mouth (active flexion and supination of the arm and passive pronation) Reaching to the left and right (active protraction of the scapula) Pulling and pushing a light object on a table EMG measures: m. biceps brachii - m. lateral deltoid - m. triceps brachii - m. trapezius descendens - m. pectoralis major Maximum Voluntary Contraction - m. biceps brachii - m. lateral deltoid - m. triceps brachii - m. trapezius descendens - m. pectoralis major | — |
Secondary
| Measure | Time frame |
|---|---|
| fatigue (Numeric Rating Scale) pain (Numeric Rating Scale) and location | — |
Countries
Netherlands